A phase I, double-blind, placebo-controlled, randomized, multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of PF 04447943 in mild-to-moderate Alzheimer's disease subjects on stable donepezil therapy

Authors
Category Primary study
JournalAlzheimer's and Dementia
Year 2011
This article has no abstract
Epistemonikos ID: 3164c25f16d2042d30ef21b816fe5cb1519c10ee
First added on: Feb 04, 2025